Company profile
Vasamed, Inc.
OTC: VSMD · Healthcare · Medical - Instruments & Supplies
#845 of 1,422 Healthcare companies by revenue71st-percentile growth
EA Score
——FH —DQ —GM —SS 37
v0.1 · 5/100 weight · pillars only
↑ operating margin, listing tenure · ↓ market scale, return on equity
Methodology →Revenue TTM
$2.0M
Rev growth YoY (TTM)
+70.0%
Net income (FY)
-$4.9M
Employees
5
as of 2026-07-12
Market cap
$802
as of 2026-07-12
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$1.4M$1.4M2005
Net income-$4.9M-$4.9M2005
Operating income$4.7M$4.7M2005
Total assets$1.6M$1.6M2005
Liabilities$1.0M$1.0M2005
Equity$594.9k$594.9k2005
Revenue trend
FY1998 – FY2005 · USD
FY98
FY99
FY00
FY01
FY02
FY03
FY04
FY05
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Vasamed, Inc.’s revenue?
Vasamed, Inc. booked $1.4M in FY2005 revenue, growing 30% year over year — faster than most Healthcare companies we track, at a -352.6% net margin.
Peers · Healthcare
Outlook Therapeutics, Inc.22DAvenue Therapeutics, Inc.25DWinston Pharmaceuticals, Inc.——Northwest Biotherapeutics, Inc.40DAffymax, Inc.——CannaPharmaRX, Inc.38DNeighbors
Hennepin →Key facts
CEOPaulita LaPlante
SectorHealthcare
IndustryMedical - Instruments & Supplies
HeadquartersEden Prairie, MN
ExchangeOTC: VSMD
Employees5
IPO date1996-02-14
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.